Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Mitochondria may influence how cells respond to radiation, affecting nearby non-irradiated cells.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.